-
FDA OKs garadacimab-gxii as prophylaxis for hereditary angioedema
09 Jul 2025 18:15 GMT
… State University.
Patients with hereditary angioedema self-administer garadacimab-gxii once … autoinjector. Image: Adobe Stock
“Hereditary angioedema significantly affects patients’ quality … role with the US Hereditary Angioedema Association; a director role …
-
FDA Approves Sebetralstat for Hereditary Angioedema
07 Jul 2025 22:10 GMT
… -gxii), the only prophylactic hereditary angioedema (HAE) treatment targeting factor … gxii-the-only-prophylactic-hereditary-angioedema-hae-treatment-targeting-factor … adolescent and adult patients with hereditary angioedema (HAE). ClinicalTrials.gov. …
-
FDA Approves Ekterly, First Oral Treatment for Hereditary Angioedema
07 Jul 2025 22:11 GMT
… treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric … director of the U.S. Hereditary Angioedema Association Center at the University …
-
Sebetralstat FDA-Approved as First Oral, On-Demand for Hereditary Angioedema
07 Jul 2025 17:17 GMT
… treatment of acute attacks of hereditary angioedema (HAE) in adult and … and Clinical Director, U.S. Hereditary Angioedema Association Center at the University … al. On-demand Treatment Of Hereditary Angioedema Attacks With Sebetralstat In Adolescents …
-
FDA approves KalVista’s Ekterly for hereditary angioedema
07 Jul 2025 15:57 GMT
… medication for acute attacks of hereditary angioedema (HAE) in adults and in …
-
KalVista Wins OK for First On-Demand Hereditary Angioedema Pill
07 Jul 2025 15:05 GMT
… Pharmaceuticals’ sebetralstat to treat acute hereditary angioedema attacks in patients 12 years … and on-demand treatment for hereditary angioedema (HAE), according to KalVista’s …
-
Astria Therapeutics to Present at Upcoming 2025 US Hereditary Angioedema Association National Summit
07 Jul 2025 12:22 GMT
… posters at the 2025 US Hereditary Angioedema Association (HAEA) National Summit, … of Navenibart in Participants with Hereditary Angioedema (HAE): Initial Combined Results … Rescue Medication in Patients with Hereditary Angioedema (HAE): Interim Results from …
-
KalVista Pharmaceuticals Announces FDA Approval of EKTERLY® (sebetralstat), First and Only Oral On-demand Treatment for Hereditary Angioedema
07 Jul 2025 10:34 GMT
… and Clinical Director, U.S. Hereditary Angioedema Association Center at the University … of the live event.
About Hereditary Angioedema
Hereditary angioedema (HAE) is a rare genetic … treat sudden (acute) attacks of hereditary angioedema (HAE) in adults and …
-
A Look Ahead in Life Sciences: What We Are Tracking in the Third Quarter of 2025 and Beyond
09 Jul 2025 23:18 GMT
… that FDA approved KalVista’s hereditary angioedema treatment following a mid-June …
-
Second Half Milestones, KalVista’s Surprise Approval, Another RFK Jr. Lawsuit, More
09 Jul 2025 12:45 GMT
… KalVista’s Pharmaceuticals’ Ekterly for hereditary angioedema. The road to approval for …